Inventor · disambiguated record
Lisa Stanek
Also filed as: STANEK LISA · STANEK LISA M
15 granted patents·5 pending applications·43 citations·filing 2010–2025
91Inventor score
Files withGENZYME CORP11IONIS PHARMACEUTICALS INC6AFFINIA THERAPEUTICS INC1HUNG GENE1ISIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
20 records- 0195US9273315B2Modulation of huntingtin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·19 cites·14 claims
- 0293US10837016B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·2 cites·16 claims
- 0390US10619158B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Apr 14, 2020·2 cites·16 claims
- 0489US9683236B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·5 cites·16 claims
- 0588US12241078B2AAV vectors for retinal and CNS gene therapyGENZYME CORP·Filed 2021·Granted Mar 4, 2025·1 cites·37 claims
- 0687US11421231B2Modulation of Huntington expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 23, 2022·1 cites·16 claims
- 0785US8906873B2Modulation of huntingtin expressionHUNG GENE·Filed 2010·Granted Dec 9, 2014·8 cites·8 claims
- 0884US10202603B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·16 claims
- 0982US12297431B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
- 1080US12465657B2Enhanced delivery of viral particles to the striatum and cortexGENZYME CORP·Filed 2022·Granted Nov 11, 2025·0 cites·10 claims
- 1180US12331296B2Variant RNAiGENZYME CORP·Filed 2023·Granted Jun 17, 2025·0 cites·23 claims
- 1280US11603529B2Variant RNAiGENZYME CORP·Filed 2018·Granted Mar 14, 2023·1 cites·43 claims
- 1380US10760079B2Variant RNAiGENZYME CORP·Filed 2019·Granted Sep 1, 2020·1 cites·41 claims
- 1480US2024182896A1VARIANT RNAiGENZYME CORP·Filed 2023·Application pending·0 cites
- 1576US2025290075A1VARIANT RNAiGENZYME CORP·Filed 2025·Application pending·0 cites
- 1671US2025320522A1Aav vectors for retinal and cns gene therapyGENZYME CORP·Filed 2025·Application pending·0 cites
- 1770US10450563B2Variant RNAiGENZYME CORP·Filed 2016·Granted Oct 22, 2019·1 cites·33 claims
- 1869US11781137B2Variant RNAiGENZYME CORP·Filed 2020·Granted Oct 10, 2023·0 cites·31 claims
- 1955US2023034817A1Recombinant aav for treatment of neural diseaseAFFINIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2049US2019111157A1Enhanced delivery of viral particles to the striatum and cortexGENZYME CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lisa Stanek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →